Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge
Authors:
Open Access
- 17 May 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 19 (5) , e1011051
Abstract
Understanding immune mechanisms that mediate malaria protection is critical for improving vaccine development. Vaccination with radiation-attenuated Plasmodium falciparum sporozoites (PfRAS) induces high level of sterilizing immunity against malaria and serves as a valuable tool for the study of protective mechanisms. To identify vaccine-induced and protection-associated responses during malarial infection, we performed transcriptome profiling of whole blood and in-depth cellular profiling of PBMCs from volunteers who received either PfRAS or noninfectious mosquito bites, followed by controlled human malaria infection (CHMI) challenge. In-depth single-cell profiling of cell subsets that respond to CHMI in mock-vaccinated individuals showed a predominantly inflammatory transcriptome response. Whole blood transcriptome analysis revealed that gene sets associated with type I and II interferon and NK cell responses were increased in prior to CHMI while T and B cell signatures were decreased as early as one day following CHMI in protected vaccinees. In contrast, non-protected vaccinees and mock-vaccinated individuals exhibited shared transcriptome changes after CHMI characterized by decreased innate cell signatures and inflammatory responses. Additionally, immunophenotyping data showed different induction profiles of vδ2+ γδ T cells, CD56+ CD8+ T effector memory (Tem) cells, and non-classical monocytes between protected vaccinees and individuals developing blood-stage parasitemia, following treatment and resolution of infection. Our data provide key insights in understanding immune mechanistic pathways of PfRAS-induced protection and infective CHMI. We demonstrate that vaccine-induced immune response is heterogenous between protected and non-protected vaccinees and that inducted-malaria protection by PfRAS is associated with early and rapid changes in interferon, NK cell and adaptive immune responses. Trial Registration: ClinicalTrials.gov NCT01994525.Keywords
Funding Information
- National Institutes of Health (U19AI128914)
- National Institutes of Health (U19AI128914)
- Bill and Melinda Gates Foundation (GHVAP NG-ID18-Stuart)
- National Institute of General Medical Sciences (P41GM109824)
This publication has 86 references indexed in Scilit:
- Protective CD8+ T lymphocytes in Primates Immunized with Malaria SporozoitesPLOS ONE, 2012
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variationNucleic Acids Research, 2012
- Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and virusesNature Immunology, 2010
- The extensive polymorphism of KIR genesImmunology, 2009
- flowCore: a Bioconductor package for high throughput flow cytometryBMC Bioinformatics, 2009
- Immunization with Radiation-Attenuated Plasmodium berghei Sporozoites Induces Liver cCD8α+DC that Activate CD8+T Cells against Liver-Stage MalariaPLOS ONE, 2009
- Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malariaProceedings of the National Academy of Sciences, 2008
- A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus ErythematosusImmunity, 2008
- Genetically AttenuatedPlasmodium bergheiLiver Stages Induce Sterile Protracted Protection That Is Mediated by Major Histocompatibility Complex Class I–Dependent Interferon‐γ–Producing CD8+T CellsThe Journal of Infectious Diseases, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005